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Abstract
The translation inhibitor and tumor suppressor Pdcd4 was reported to be lost in various
tumors and put forward as prognostic marker in tumorigenesis. Decreased Pdcd4 protein
stability due to PI3K-mTOR-p70S6K1 dependent phosphorylation of Pdcd4 followed by β-
TrCP1-mediated ubiquitination, and proteasomal destruction of the protein was character-
ized as a major mechanism contributing to the loss of Pdcd4 expression in tumors. In an
attempt to identify stabilizers of Pdcd4, we used a luciferase-based high-throughput com-
patible cellular assay to monitor phosphorylation-dependent proteasomal degradation of
Pdcd4 in response to mitogen stimulation. Following a screen of approximately 2000 com-
pounds, we identified 1,2-bis(4-chlorophenyl)disulfide as a novel Pdcd4 stabilizer. To deter-
mine an initial structure-activity relationship, we used 3 additional compounds, synthesized
according to previous reports, and 2 commercially available compounds for further testing,
in which either the linker between the aryls was modified (compounds 2–4) or the chlorine
residues were replaced by groups with different electronic properties (compounds 5 and 6).
We observed that those compounds with alterations in the sulfide linker completely lost the
Pdcd4 stabilizing potential. In contrast, modifications in the chlorine residues showed only
minor effects on the Pdcd4 stabilizing activity. A reporter with a mutated phospho-degron
verified the specificity of the compounds for stabilizing the Pdcd4 reporter. Interestingly, the
active diaryl disulfides inhibited proliferation and viability at concentrations where they stabi-
lized Pdcd4, suggesting that Pdcd4 stabilization might contribute to the anti-proliferative
properties. Finally, computational modelling indicated that the flexibility of the disulfide linker
might be necessary to exert the biological functions of the compounds, as the inactive com-
pound appeared to be energetically more restricted.
PLOS ONE | DOI:10.1371/journal.pone.0151643 March 16, 2016 1 / 14
OPEN ACCESS
Citation: Schmid T, Blees JS, Bajer MM, Wild J,
Pescatori L, Cuzzucoli Crucitti G, et al. (2016) Diaryl
Disulfides as Novel Stabilizers of Tumor Suppressor
Pdcd4. PLoS ONE 11(3): e0151643. doi:10.1371/
journal.pone.0151643
Editor: Xinbin Chen, University of California at Davis,
UNITED STATES
Received: December 22, 2015
Accepted: March 2, 2016
Published: March 16, 2016
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced, distributed,
transmitted, modified, built upon, or otherwise used
by anyone for any lawful purpose. The work is made
available under the Creative Commons CC0 public
domain dedication.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by the DFG
(GRK1172 (MMB) and SCHM2663/3 (TS)). This
research was further supported in part by the
Intramural Research Program of the NIH, National
Cancer Institute, Center for Cancer Research. This
project was also funded in part with Federal funds
from the Frederick National Laboratory for Cancer
Research, National Institutes of Health, under
contract HHSN261200800001E. The content of this
publication does not necessarily reflect the views or
policies of the Department of Health and Human
Introduction
The tumor suppressor Programmed cell death 4 (Pdcd4) is lost in a number of different tumors
such as lung, colon, breast, ovarian, and pancreatic cancer [1,2]. Loss of Pdcd4 enhances neo-
plastic transformation, activator protein 1 (AP-1) transactivation, intravasation, and invasion
in vitro [3,4] and Pdcd4-deficient mice appear more susceptible to the two stage skin carcino-
genesis model, whereas transgenic overexpression of Pdcd4 decreased papilloma incidence and
multiplicity in this model [5,6]. In addition, Pdcd4-deficient mice were shown to spontane-
ously develop lymphoma restricting their life span [7]. On the molecular level, Pdcd4 inhibits
translation rather than transcription by interfering with the activity of the RNA helicase
eukaryotic initiation factor (eIF) 4A through competition with the scaffold protein eIF4G [8].
Interestingly, in contrast to most tumor suppressors, Pdcd4 appears not to be inactivated muta-
tionally [9]. Instead there is mounting evidence that Pdcd4 expression in tumors is predomi-
nantly controlled at a post-transcriptional level. In addition to the microRNA-21-dependent
repression of Pdcd4 expression [10], increased proteasomal degradation contributes to the reg-
ulation of Pdcd4 levels in response to mitogens and inflammatory tumor environments
[6,11,12]. Mechanistically, Pdcd4 protein contains a 70-kDa ribosomal protein S6 kinase 1
(p70S6K1) consensus phosphorylation sequence directly followed by the binding motif for the
E3-ubiquitin ligase β-transducin repeat-containing protein (β-TrCP). Activation of p70S6K1 in
response to mitogens such as the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)
results in phosphorylation of Pdcd4, followed by binding of β-TrCP, polyubiquitination, and
subsequent proteasomal degradation of Pdcd4 [6,11].
Since stabilization of Pdcd4 emerged as an interesting concept for novel tumor therapeutics,
we set out to identify novel Pdcd4 stabilizers. Previously, we already identified a number of
Pdcd4 stabilizers [13–17]. Yet, these compounds were all natural products generally character-
ized by rather complex structures not easy to use as scaffolds to perform structure-activity rela-
tionship studies. Therefore, we decided to screen an in-house chemical synthetic library
available in our laboratories. Here we present the identification of a novel group of Pdcd4 stabi-
lizers providing the basis for an initial structure-activity relationship determination.
Materials and Methods
Reagents
All chemicals were purchased from Sigma-Aldrich (Schnelldorf, Germany) if not indicated
otherwise. Rapamycin and TPA (12-O-tetradecanolyphorbol-13-acetate) were purchased from
LC Laboratories (Woburn, MA, USA).
Chemistry
Melting points were determined on a Bibby Stuart Scientific SMP1 melting point apparatus
and are uncorrected. Infrared spectra were recorded on a Perkin-Elmer Spectrum-one spectro-
photometer. 1H NMR and 13C NMR spectra were recorded at 400 MHz and 100 MHz, respec-
tively, on a Bruker AC 400 Ultrashield 10 spectrophotometer (400 MHz). Dimethylsulfoxide-
d6 99.9% (code 44,139–2) and deuterochloroform 98.8% (code 41,675–4) of isotopic purity
(Aldrich) were used. Column chromatographies were performed on a silica gel (Merck; 70–230
mesh) column. All compounds were routinely checked on thin layer chromatography using
aluminum-baked silica gel plates (Fluka DC-Alufolien Kieselgel 60 F254). Developed plates
were visualized by UV light. Solvents were reagent grade and, when necessary, were purified
and dried by standard methods. Concentration of solutions after reactions and extractions
involved the use of rotary evaporator (Büchi) operating at a reduced pressure (ca. 20 Torr).
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Organic solutions were dried over anhydrous sodium sulfate (Merck). All reactions were car-
ried out under nitrogen; all solvents were freshly distilled under nitrogen and stored over
molecular sieves for at least 3 h prior to use.
Compounds 1 (1,2-bis(4-chlorophenyl)disulfide) [18,19], 2 (4-chloro-N-(4-chlorophenyl)
benzamide) [20], 3 ((E)-1,2-bis(4-chlorophenyl)diazene), and 4 (1,2-bis(4-chlorophenyl)
hydrazine) [21] were synthesized as previously reported in the literature. Compounds 5
(1,2-bis(4-methoxyphenyl)disulfide) and 6 (1,2-bis(4-nitrophenyl)disulfide) were purchased
from Sigma-Aldrich.
Cell culture
HEK293 cells were purchased from ATCC-LGC Standard GmbH (Wesel, Germany). HEK293
Pdcd4-luc cells were maintained in DMEM supplemented with 10% FBS, 100 U/mL penicillin,
100 μg/mL streptomycin, 2 mM L-glutamine, and 3 μg/mL blasticidin as previously described
[14,15]. Cells were cultivated in a humidified atmosphere with 5% CO2 at 37°C. Medium, sup-
plements, and FBS came from PAA (Linz, Austria).
Pdcd4 stabilization assay
Pdcd4 stabilization was assessed using a luciferase-based assay as previously described [15].
Briefly, HEK293 cells stably expressing either Pdcd4(39–91)luc or Pdcd4(mut39-91)luc were seeded
in a 96-well plate (1 x 104/well) and allowed to attach for 18 h before treatment. After appropri-
ate incubations, cells were harvested in luciferase lysis buffer (25 mM Tris, 2 mM DTT, 1% Tri-
ton-X-100, 10% glycerol, pH 7.8) and frozen at -20°C for at least 2 h. After lysis at room
temperature, luminescence was measured using firefly luciferase substrate solution (20 mM tri-
cine, 2.67 mM 4MgCO3Mg(OH)25H2O, 1.07 mMMgSO47H2O, 100 μM EDTA, 33.3 mM
DTT, 530 μMATP, 0.213 mg/mL coenzyme A, 470 mM D-luciferin) on a Mithras LB 940
(Berthold, Bad Wildbad, Germany). Pdcd4(39–91)luc expressing cells were used to determine
Pdcd4 stabilization and the stabilizing activity of test samples was calculated using the follow-
ing formula based on the relative light units (RLU) measured:
Pdcd4ð3991Þ stabilization ½% ¼ ðRLUCpd  RLUTPAÞ = ðRLUDMSO  RLUTPAÞ  100:
Pdcd4(mut39-91)luc expressing cells served as a specificity control and effects were calculated
according to the following formula:
Pdcd4ðmut3991Þ RLU ½% ¼ RLUCpd = RLUTPA  100:
Proliferation assay
HEK293 cells (1 x 104/well), seeded in 96-well plates one day prior to the experiment, were
treated as indicated and proliferation was analyzed over a time course of 5 days using an Incu-
Cyte1 Live-Cell Imaging System (Essen Bioscience). Briefly, proliferation was assessed as
increase in confluency of the cell layer by automated real-time, live-cell imaging every 4 h
using the IncuCyte. Mean values of 3 wells per treatment were determined for at least 3 inde-
pendent experiments.
Cell cycle analysis
HEK293 cells (8 x 104/well), seeded in 6-well plates one day prior to the experiment, were
treated as indicated. Cell cycle distribution was assessed by 7-Amino-Actinomycin D (7-AAD)
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staining. Briefly, after treatment the cells were permeabilized using PBS + (PBS supplemented
with 1.1 g/l sucrose, 0.5 mM EDTA and 50 μg/ml RNase A). Stainings were carried out in
PBS+, 10% NP-40, and 5% 7-AAD (BD Pharmingen) and detected on a LSRFortessa flow
cytometer (BD Biosciences).
Cell death detection
HEK293 cells (8 x 104/well), seeded in 6-well plates one day prior to the experiment, were
treated as indicated. Viability was assessed using Annexin V/7-AAD co-stainings. Briefly, after
treatment the cells were harvested in PBS and directly stained with 2% Annexin V-FITC
(ImmunoTools) and 1% 7-AAD. Measurements were carried out on a LSRFortessa flow
cytometer.
Computational study
Conformational analyses were carried out using the software VEGAZZ rel.3.0.5.12. The sys-
tematic approach was chosen to explore the conformational space around the three rotatable
bonds (σ1, σ2, σ3), with 60° step increments. For each compound all the 216 generated confor-
mations were minimized using SP4 force field, and the energy was plotted against the number
of the conformation.
Statistical analysis
At least three independent experiments were performed. Data are presented as means ± SEM.
Statistical analyses were performed using Student’s t-test.
Results and Discussion
We previously presented a high-throughput compatible, cell-based assay to identify com-
pounds stabilizing Pdcd4 from TPA-induced degradation [13–15]. Hereto, we introduced a
vector containing the phosphorylation-dependent degradation domain of Pdcd4 (aa 39–91)
fused to luciferase (Pdcd4(39-91)luc) into HEK293 cells to follow TPA-induced degradation of
Pdcd4. A vector where the critical serine residues 67, 71, and 76 within the phospho-degron
were mutated to alanines (Pdcd4(mut39–91)luc) served as a TPA-insensitive control [14]. Impor-
tantly, due to the nature of the assay observed effects can be attributed solely to altered Pdcd4
protein stability, while mechanisms affecting Pdcd4 synthesis, e.g. via microRNA-21-depen-
dent reduction of Pdcd4 mRNA stability or translation, can be excluded since these would not
affect the reporter vector as the respective mRNA-target sequences are not present. Screening
of a chemical library of approximately 2000 compounds including compounds with antifungal,
antiviral, or antitumor activities, as well as their synthetic intermediates, we identified 1,2-bis
(4-chlorophenyl)disulfide (1) (Fig 1) to stabilize Pdcd4 from TPA-induced degradation with a
maximal Pdcd4 stabilizing activity at 10 μM. As structure and synthesis of this diaryl disulfide
were previously described [18,19], we aimed at generating related compounds that could pro-
vide further insights into the structure-activity relationship concerning Pdcd4 stabilization.
First we decided to modify the linker between the aryl moieties of 1. Thus, the amide 2, the
azo derivative 3, and the corresponding hydrazine 4 were synthesized as previously reported in
the literature [20,21]. We further included two commercially available derivatives, in which the
chlorine atoms of 1 were replaced by either electron donating methoxy groups (5) and electron
withdrawing NO2 group (6) for further analyses. Thus, a total of 6 compounds was analyzed in
this study (Fig 1).
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Determination of the Pdcd4 stabilizing activities
We initially tested all compounds for their ability to stabilize Pdcd4. To this end, we co-treated
Pdcd4(39–91)luc expressing stability reporter cells with TPA (10 nM) and compounds 1, 2, 3, 4,
5, or 6 (0.1 to 30 μM) for 8 h. Compound 6 was only used up to 10 μM due to insolubility at
higher concentrations. The Pdcd4 stabilizing activity was determined relative to the difference
between DMSO-treated control and TPA-treated cells, where DMSO-treated cells was set as
100% and TPA-treated cells as 0%. Recovery of luciferase activity was considered as Pdcd4 sta-
bilization as previously described [15]. In line with our previous observation, freshly synthe-
sized compound 1 showed maximal Pdcd4 stabilization at 10 μM, with a sharp loss of activity
at 30 μM (Fig 2). Compound 2 showed slightly elevated luciferase levels across all concentra-
tions tested, whereas the luciferase signal steadily increased in response to compounds 3 and 4.
Compound 5 showed some Pdcd4 stabilization at the highest concentrations used (30 μM),
whereas compound 6 showed enhanced activity starting at 3 μM (Fig 2).
Fig 1. Chemical structures. Structures of compounds 1 (1,2-bis(4-chlorophenyl)disulfide), 2 (4-chloro-N-
(4-chlorophenyl)benzamide), 3 ((E)-1,2-bis(4-chlorophenyl)diazene), 4 (1,2-bis(4-chlorophenyl)hydrazine), 5
(1,2-bis(4-methoxyphenyl)disulfide), and 6 (1,2-bis(4-nitrophenyl)disulfide).
doi:10.1371/journal.pone.0151643.g001
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To evaluate the specificity of the observed activities, we treated the TPA-insensitive
Pdcd4(mut39–91)luc expressing cell line in the same manner as the Pdcd4 stability reporter cell
line. Since TPA did not alter the luciferase activity of this reporter as compared to DMSO, all
compounds were evaluated relative to TPA-only as they were administered in combination
with TPA (10 nM). Compound 1 did not affect the luciferase activity up to 10 μM. Yet, at
30 μM of compound 1 luciferase activity was markedly reduced (Fig 3). The loss of luciferase
activity at 30 μM corresponded well with the marked reduction of the activity at 30 μM
observed in the stability reporter cell line (Fig 2), suggestive for toxicity and/or nonspecific
luciferase inhibition to overcome the Pdcd4 stabilizing capacity.
Compounds 2, 3, and 4 displayed either stable, but elevated luciferase levels (2) or a steady
increase (3, 4) in luciferase activity in the specificity control cells (Fig 3), following the same
Fig 2. Pdcd4 stabilizing activity.HEK293 cells stably expressing the Pdcd4 stability reporter Pdcd4(39–91)luc were incubated for 8 h with TPA [10 nM] in
combination with increasing concentrations (0.1–30 μM) of compounds 1, 2, 3, 4, 5, and 6. Pdcd4 stabilizing activity was determined relative to Δ(RLUDMSO–
RLUTPA). Data are presented as means ± SEM of at least 3 independent experiments (* p<0.05, ** p<0.01, *** p<0.01).
doi:10.1371/journal.pone.0151643.g002
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pattern as observed in the Pdcd4 stability reporter cells (Fig 2). As the luciferase activities
behaved similarly in control and Pdcd4 stability reporter cells, these effects are likely to be
attributable to a general effect on luciferase activity rather than to Pdcd4 stabilization by com-
pounds 2, 3, and 4.
In contrast, compounds 5 or 6 did not show elevated luciferase activities in the mutant cell
line. Thus, the suggested Pdcd4 stabilizing activities observed for these compounds appeared
not to be due to nonspecific effects. In the case of compound 5, higher concentrations (10 and
30 μM) even slightly inhibited the luciferase signal (Fig 3), where the Pdcd4 stabilization was
still observed. Thus, while the elevated Pdcd4 stabilizing activity (Fig 2) was not overcome by
the general luciferase inhibition, this might cause an underestimation of the real stabilization
potential of compound 5.
Fig 3. Nonspecific activity.HEK293 cells stably expressing Pdcd4(mut39–91)luc were incubated for 8 h with TPA [10 nM] in combination with increasing
concentrations (0.1–30 μM) of compounds 1, 2, 3, 4, 5, and 6. Luciferase activity is given relative to TPA-treated controls. Data are presented as
means ± SEM of at least 3 independent experiments (* p<0.05, ** p<0.01, *** p<0.01).
doi:10.1371/journal.pone.0151643.g003
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In summary, in addition to compound 1, compounds 5 and 6 appeared to stabilize Pdcd4
without affecting the specificity luciferase reporter. In the case of compounds 1 and 5, the loss
of luciferase activity at 30 μMmight be an indicator for toxicity. Increasing toxicity associated
with elevated Pdcd4 levels does not come as a surprise, since Pdcd4 was previously shown to
contribute to cell death [22]. Compounds 2, 3, and 4 affected both reporter constructs simi-
larly, i.e. lacked specific Pdcd4 stabilizing activity.
Taken together these data suggest that compound 1, and to a lesser extend compounds 5
and 6, contain concentration-dependent Pdcd4 stabilizing activity. Thus, while replacement of
the chlorine atoms with different substituents (compounds 5 and 6) only slightly modulated
the Pdcd4 stabilizing activity of the parent compound 1, altering the linker between the two
phenyl rings of 1 by substituting the disulfide by an amide function, a diazo group, or a hydra-
zine moiety (compounds 2, 3, and 4, respectively) completely abolished the activity.
Determination of the proliferation, cell cycle, and viability inhibitory
capacities
While the anti-tumorigenic properties of Pdcd4 were primarily attributed to its transformation
inhibitory function [23], Pdcd4, as the name implies, was tightly linked with the induction of
apoptosis as well [22,24]. Since we observed that the most potent Pdcd4 stabilizing compounds
1 and 5 elicited a marked loss of luciferase activity at 30 μM in target as well as off-target cells,
which could be indicative for a loss of viability, we aimed at determining the impact of these
compounds on cell proliferation. To this end, HEK293 cells were plated at low densities and
their confluency was followed every 4 hours for 5 days via automated microscopy in an Incu-
Cyte instrument in the presence or absence of compounds (1–30 μM). In line with the lacking
Pdcd4 stabilization, compounds 2, 3, and 4 did not affect proliferation, i.e. proliferation was
not altered at any concentration as compared to the control (Fig 4). In contrast, the three com-
pounds exerting Pdcd4 stabilizing activity (compounds 1, 5, and 6) markedly inhibited prolif-
eration starting at concentrations of 10 μM (Fig 4, yellow lines). While this correlated well with
the concentrations effectively stabilizing Pdcd4 for compounds 1 and 6 (Fig 4), compound 5
showed only a minimal Pdcd4 stabilizing activity at this concentration. In line with their differ-
ences in Pdcd4 stabilizing potency, compound 1 appeared to be more effective in blocking pro-
liferation at 10 μM. At 30 μM (red lines), where compound 6 could not be tested, compounds 1
and 5 completely inhibited proliferation, yet still allowing for the detection of Pdcd4 stabilizing
properties at least in the case of compound 5. This observation further corroborates the above-
described finding where the luciferase activity of the off-target cell line was inhibited by 85% at
a concentration of 30 μM of compound 1, whereas compound 5 inhibited nonspecific lucifer-
ase only by 35% at 30 μM (Fig 3). While the correlation between Pdcd4 stabilization and anti-
proliferative effects appeared to be rather weak in the case of compound 5, the different expo-
sure times need to be kept in mind, i.e. while in the luciferase-based assays compound-expo-
sure was 8 h, the proliferation assay was carried out for 5 d.
As it was previously shown that stabilization of Pdcd4 can affect the cell cycle [14,25], we
next evaluated if the compounds induce changes in cell cycle progression. To this end, we incu-
bated cells for 24 h with the compounds, and then determined cell cycle phases via incorpo-
ration of 7-AAD in permeabilized cells. In line with our above-shown findings, compounds 2,
3, and 4 did not alter the cell cycle (Fig 5). Furthermore, compounds 1, 5, and 6 lead to a signif-
icant increase of cells in sub-G1 phase, which is indicative for enhanced cell death rather than
for changes in cell cycle progression. Again, compound 1 showed the most pronounced effects,
whereas compound 6 appeared least potent, compound 5 leading to intermediate changes.
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Since these observations pointed to toxicity rather than to proliferation inhibition, we next
analyzed if cells underwent apoptotic or necrotic cell death in response to the compounds.
Therefore, cells treated for 24 h with the compounds were stained with Annexin V and 7-AAD
without permeabilization. Apoptotic cells should display phosphatidylserine on their mem-
branes (AnV +), yet still retain intact membranes (7-AAD -), while necrotic cells should be
both AnV + and 7-AAD + due to disruption of the cellular membranes. Again only compounds
1, 5, and 6 caused a marked decrease in viable cells (AnV -/7-AAD -) and a strong and concen-
tration-dependent increase in necrotic cells (AnV +/7-AAD +) (Fig 6). The observed loss of
viability nicely correlates with both the increase in the sub-G1 fraction as well as with the inhi-
bition of proliferation. Yet, proliferation appears to be a more sensitive marker, likely due to
Fig 4. Proliferation. HEK293 cells stably expressing Pdcd4(39–91)luc were incubated for 5 days with DMSO (blue) or increasing concentrations of
compounds 1, 2, 3, 4, 5, and 6 (1 μM (green), 3 μM (violet), 10 μM (yellow), and 30 μM (red)). Confluency was assessed every 4 h in an IncuCyte instrument.
Proliferation kinetics shown are representative for at least 3 independent experiments and represent means of 3 wells treated in parallel (* p<0.05, **
p<0.01, *** p<0.01).
doi:10.1371/journal.pone.0151643.g004
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the longer time frame of exposure. The loss of viability (Fig 6) coincides closest with the non-
specific luciferase reporter (Fig 3), which reflects the same incubation conditions. Interestingly,
Pdcd4 stabilizing activities of compound 1, 5, and 6 (Fig 2) occurred at or slightly below the
viability reducing concentrations (Fig 6). Thus, diaryl disulfides appear to stabilize Pdcd4 even-
tually inducing cell death.
Computational structure activity relationship analysis
In an initial attempt to assess the influence of the conformational features of the linker region
on the biological activity, we carried out a computational study on compounds 1, 2, and 4 by
exploring the conformational space around the three rotatable bonds (σ1, σ2, σ3; Fig 7A).
Fig 5. Cell cycle.HEK293 cells stably expressing Pdcd4(39–91)luc were incubated for 24 h with DMSO (blue) or increasing concentrations of compounds 1,
2, 3, 4, 5, and 6 (3 μM (violet), 10 μM (yellow), and 30 μM (red)). Cell cycle analysis was performed after permeabilization using 7-AAD. Data are presented
as means ± SEM of at least 3 independent experiments (* p<0.05, ** p<0.01, *** p<0.01).
doi:10.1371/journal.pone.0151643.g005
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The conformations generated and minimized for compound 1 can, for the most part, be
placed into two very close clusters energy, thus indicating a high conformational flexibility.
The global minimum energy conformation presents a folded structure (Fig 7B). In contrast, the
energy plot shows that the conformations generated and minimized for compound 2 can be
roughly grouped into two energy clusters with a higher energy difference compared to com-
pound 1 indicating a lower conformational freedom. In this case, the global minimum was
found as an extended conformation with the aromatic ring almost perpendicular. The confor-
mations generated and minimized for compound 4 (Fig 7C), from the point of view of the
energy are quite close to that of the global minimum but with a greater number of conforma-
tions at a higher energy content than what is observed for compound 1. The global minimum
was found as extended conformation with the two aromatic rings slightly inclined relatively to
Fig 6. Viability.HEK293 cells stably expressing Pdcd4(39–91)luc were incubated for 24 h with DMSO (blue) or increasing concentrations of compounds 1, 2,
3, 4, 5, and 6 (3 μM (violet), 10 μM (yellow), and 30 μM (red)). Cell death analysis was performed using Annexin V and 7-AAD co-staining. Data are presented
as means ± SEM of at least 3 independent experiments (* p<0.05, ** p<0.01, *** p<0.01).
doi:10.1371/journal.pone.0151643.g006
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each other. Taken together, our computational study revealed a higher flexibility of compound
1, due to the disulfide group, compared to the hydrazine (compound 4), and even more so to
the amide (compound 2). Furthermore, compound 1 appears to possess a folded global mini-
mum conformation, whereas compounds 2 and 4 appear almost extended, which may contrib-
ute to the difference in activity found in the compounds tested.
Conclusions
In the present study we identified a novel stabilizer of tumor suppressor Pdcd4, 1,2-bis
(4-chlorophenyl)disulfide (compound 1), which not only stabilized Pdcd4 but also inhibited
cellular proliferation. Interestingly, substituting the disulfide linker region completely abol-
ished the Pdcd4 stabilizing and proliferation inhibitory activities, whereas modulation of the
phenyl substituents only had a minor impact on the biological activity. Yet, it can be envisioned
that other modifications could enhance the Pdcd4 stabilizing potential. The need of the disul-
fide linker, which was also supported by our computational study, implies a crucial role of this
Fig 7. Conformational analysis of compounds 1, 2 and 4. (A) A systematic approach was chosen to
explore the conformational space around the three rotable bonds. (B-D) Global minimum energy
conformations (left panel) and energy plots (right panel) of compounds 1 (B), 2 (C), and 4 (D).
doi:10.1371/journal.pone.0151643.g007
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specific moiety for exerting the Pdcd4 stabilizing function of this compound. Nevertheless, fur-
ther studies are needed to shed light on the molecular target of the diaryl disulfides mediating
the Pdcd4 stabilizing effect, also exploring the exact chemical mode of interaction. Thus, while
the compounds so far display rather low activities, it remains to be seen, if diaryl sulfide-based
compounds can be optimized to yield more potent Pdcd4 stabilizers.
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